Risk Factors for Interstitial Cystitis in the General Population and in Individuals With Depression
- PMID: 30943693
- PMCID: PMC6449659
- DOI: 10.5213/inj.1836182.091
Risk Factors for Interstitial Cystitis in the General Population and in Individuals With Depression
Abstract
Purpose: To identify risk factors for interstitial cystitis (IC), a chronic bladder disorder that may have a significant detrimental impact on quality of life, in the general population and in individuals with depression.
Methods: This was a comparative study using a US claims database. Adults who had records of a visit to the health system in 2010 or later were included. The outcome was the development of IC within 2 years after the index date. The index date for the general population was the first outpatient visit, and for individuals with depression, it was the date of the diagnosis of depression. IC was defined using the concepts of ulcerative and IC. We included all medical conditions present any time prior to the index visit as potential risk factors.
Results: The incidence of IC was higher in individuals with depression than in the general population. Of the 3,973,000 subjects from the general population, 2,293 (0.06%) developed IC within 2 years. Of the 249,200 individuals with depression, 320 (0.13%) developed IC. The characteristics of the individuals who developed IC were similar in both populations. Those who developed IC were slightly older, more likely to be women, and had more chronic pain conditions, malaise, and inflammatory disorders than patients without IC. In the general population, subjects who developed IC were more likely to have mood disorders, anxiety, and hypothyroidism.
Conclusion: The incidence of IC was higher in individuals with depression. Subjects who developed IC had more chronic pain conditions, depression, malaise, and inflammatory disorders.
Keywords: Depression; Inflammation; Interstitial cystitis; Retrospective cohort study; Risk factors.
Conflict of interest statement
All authors are employees of Janssen Research & Development, LLC. Janssen Research & Development, LLC has an interest in depression. There is no mention of any medical product.
Figures
Similar articles
-
Increased risks of healthcare-seeking behaviors of anxiety, depression and insomnia among patients with bladder pain syndrome/interstitial cystitis: a nationwide population-based study.Int Urol Nephrol. 2015 Feb;47(2):275-81. doi: 10.1007/s11255-014-0908-6. Epub 2015 Jan 11. Int Urol Nephrol. 2015. PMID: 25577231
-
Comorbidities of bladder pain syndrome/interstitial cystitis: a population-based study.BJU Int. 2012 Dec;110(11 Pt C):E903-9. doi: 10.1111/j.1464-410X.2012.11539.x. Epub 2012 Sep 28. BJU Int. 2012. PMID: 23020942
-
Interstitial Cystitis: Cost, treatment and co-morbidities in an employed population.Pharmacoeconomics. 2006;24(1):55-65. doi: 10.2165/00019053-200624010-00005. Pharmacoeconomics. 2006. PMID: 16445303
-
Psychosocial co-morbidities in Interstitial Cystitis/Bladder Pain syndrome (IC/BPS): A systematic review.Neurourol Urodyn. 2018 Mar;37(3):926-941. doi: 10.1002/nau.23421. Epub 2017 Oct 9. Neurourol Urodyn. 2018. PMID: 28990698 Free PMC article.
-
Molecular pathogenesis of interstitial cystitis/bladder pain syndrome based on gene expression.J Cell Physiol. 2019 Aug;234(8):12301-12308. doi: 10.1002/jcp.28009. Epub 2019 Jan 4. J Cell Physiol. 2019. PMID: 30609029 Review.
Cited by
-
Association between Chronic Interstitial Cystitis and Herpes Zoster.Int J Environ Res Public Health. 2020 Mar 26;17(7):2228. doi: 10.3390/ijerph17072228. Int J Environ Res Public Health. 2020. PMID: 32224999 Free PMC article.
-
This pain drives me crazy: Psychiatric symptoms in women with interstitial cystitis/bladder pain syndrome.World J Psychiatry. 2024 Jun 19;14(6):954-984. doi: 10.5498/wjp.v14.i6.954. eCollection 2024 Jun 19. World J Psychiatry. 2024. PMID: 38984334 Free PMC article.
-
Comorbidities of bladder pain syndrome in the context of the HITOP distress category: a systematic review and meta-analysis.Int Urogynecol J. 2022 Sep;33(9):2335-2356. doi: 10.1007/s00192-022-05129-1. Epub 2022 Mar 9. Int Urogynecol J. 2022. PMID: 35262767 Free PMC article.
-
Lower Urinary Tract Inflammation and Infection: Key Microbiological and Immunological Aspects.J Clin Med. 2024 Jan 5;13(2):315. doi: 10.3390/jcm13020315. J Clin Med. 2024. PMID: 38256450 Free PMC article. Review.
-
Antioxidant, anti-inflammatory and Uroprotective effects of LAMOTRIGINE Cinnamaldehyde silver complex in cyclophosphamide-induced cystitis.Toxicol Res (Camb). 2025 Mar 27;14(2):tfaf041. doi: 10.1093/toxres/tfaf041. eCollection 2025 Apr. Toxicol Res (Camb). 2025. PMID: 40161256
References
-
- Homma Y, Ueda T, Tomoe H, Lin AT, Kuo HC, Lee MH, et al. Clinical guidelines for interstitial cystitis and hypersensitive bladder updated in 2015. Int J Urol. 2016;23:542–9. - PubMed
-
- Li GZ, Zhang N, Du P, Yang Y, Wu SL, Xiao YX, et al. Risk factors for interstitial cystitis/painful bladder syndrome in patients with lower urinary tract symptoms: a Chinese multi-center study. Chin Med J (Engl) 2010;123:2842–6. - PubMed
LinkOut - more resources
Full Text Sources